Abstract
Most national governments have created agencies with the responsibility for deciding which medicinal drugs should be imported or manufactured and made available through their health systems. Many of these agencies were set up some twenty years ago in the wake of the thalidomide disaster. Since that time they have developed in quite different ways in response to national, cultural and economic influences. Their direct cost is very small in comparison to overall health budgets but their indirect effects, both in terms of health and the economy, can be substantial.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1985 MTP Press Limited
About this chapter
Cite this chapter
Dukes, G. (1985). Introduction. In: The Effects of Drug Regulation. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7327-8_1
Download citation
DOI: https://doi.org/10.1007/978-94-011-7327-8_1
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-7329-2
Online ISBN: 978-94-011-7327-8
eBook Packages: Springer Book Archive